Leukopenia and leukocytosis are associated with early postoperative complications following aseptic revision total shoulder arthroplasty

白细胞减少症和白细胞增多症与无菌性翻修全肩关节置换术后的早期并发症相关。

阅读:2

Abstract

BACKGROUND: This study investigates the association between preoperative leukopenia and leukocytosis with 30-day postoperative complications following noninfectious revision total shoulder arthroplasty (TSA). METHODS: The American College of Surgeons National Surgical Quality Improvement Program database was queried for all patients who underwent noninfectious revision TSA from 2015 to 2022. The study population was divided into three groups based on preoperative white blood cell (WBC) count: normal (WBC 4500-11,000), leukopenia (WBC ≤ 4500), and leukocytosis (WBC ≥ 11,000). Logistic regression analysis was conducted to investigate the relationship between WBC count and postoperative complications. RESULTS: Compared to normal WBC counts, leukocytosis was independently associated with an increased likelihood of experiencing any complication (OR 1.71, 95% CI 1.13-2.59; P = 0.012), sepsis (OR 5.31, 95% CI 1.38-20.37; P = 0.015), non-home discharge (OR 2.18, 95% CI 1.18-4.05; P = 0.013), readmission (OR 2.76, 95% CI 1.36-5.63; P = 0.005), and LOS > 2 days (OR 1.68, 95% CI 1.06-2.66; P = 0.028). Compared to normal WBC counts, leukopenia was independently associated with an increased likelihood of experiencing pneumonia (OR 14.98, 95% CI 2.32-96.56; P = 0.004) and readmission (OR 2.78, 95% CI 1.49-5.17; P = 0.001). CONCLUSION: The present study identified preoperative leukocytosis and leukopenia as independent risk factors for 30-day postoperative complications following revision TSA. Integrating WBC count into preoperative assessments can enhance the identification of patients at risk for postoperative complications, allowing for more tailored management strategies and potentially improving overall patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。